HHS AI Use Case Inventory 2024
The Office of the Assistant Secretary for Technology Policy’s (ASTP) Office of the Chief Artificial Intelligence Officer (OCAIO) is responsible for leading the annual HHS AI use case inventory.
This artificial intelligence (AI) use case publication requirement was first initiated by President Trump through Executive Order 13960 “Promoting the Use of Trustworthy Artificial Intelligence in the Federal Government” and further enhanced by President Biden’s Executive Order 14110 "Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence.” The Office of Management and Budget (OMB) Memoranda M-24-10 “Advancing Governance, Innovation, and Risk Management for Agency Use of Artificial Intelligence” establishes requirements and guidance for AI governance, innovation, and risk management.
Questions can be directed to HHS.CAIO@hhs.gov.
| Use Case Name | Stage of System Dev Life Cycle | Op Div/Staff Div |
|---|---|---|
| Annual Report CMC | Operation and Maintenance | FDA |
| Application-DMF Reference | Operation and Maintenance | FDA |
| Artificial Intelligence-based Deduplication Algorithm for Classification of Duplicate Reports in the FDA Adverse Event Reports (FAERS) | Implementation and Assessment | FDA |
| Development of automation tools and data warehouse to facilitate BE assessments | Acquisition and/or Development | FDA |
| DMF (Drug Master File) Facilities | Operation and Maintenance | FDA |
| Four Part Harmony Identification | Acquisition and/or Development | FDA |
| Information Visualization Platform (InfoViP) to Support Analysis of adverse event reports | Acquisition and/or Development | FDA |
| LLM-Assisted VAERS Analyses | Acquisition and/or Development | FDA |
| Pharmacovigilance machine learning to detect excess safety signal | Operation and Maintenance | FDA |
| Module 3 Faculties | Operation and Maintenance | FDA |
Quick Link 6